Halo Pharmaceutical has entered an agreement to acquire Teva’s Mirabel (Quebec) manufacturing facility. The transaction, pending negotiations of manufacturing agreements between Teva Canada and Halo, is scheduled to close June 30th. Approximately 150 employees will continue to work at Mirabel. Halo plans to grow commercial contract manufacturing and product development to support products for the Canadian market, as well as production for export outside of Canada. Once complete, the acqu...